St. Charles, MO, United States of America

Neena L Summers

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: G.d. Searle & Company, Pharmacia Corporation. Active years: 2000-2004.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Neena L Summers: Innovator in Hematopoietic Receptor Agonist Proteins

Introduction

Neena L Summers is a notable inventor based in St. Charles, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of multi-functional hematopoietic receptor agonist proteins. With a total of 2 patents, his work has implications for medical advancements and therapeutic applications.

Latest Patents

Neena's latest patents include "Fused G-CSF and IL-3 proteins and uses thereof." This patent discloses novel multi-functional hematopoietic receptor agonist proteins, along with the DNAs that encode these proteins. It also outlines methods for making and using these proteins. Another significant patent is "Multi-functional hematopoietic fusion proteins between sequence," which similarly details the development and application of multi-functional hematopoietic receptor agonist proteins.

Career Highlights

Throughout his career, Neena has worked with prominent companies such as G.D. Searle & Company and Pharmacia Corporation. His experience in these organizations has allowed him to refine his expertise in the field and contribute to groundbreaking research.

Collaborations

Neena has collaborated with several talented individuals, including Yiqing Feng and Nicholas R Staten. These partnerships have fostered innovation and have been instrumental in advancing his research.

Conclusion

Neena L Summers is a distinguished inventor whose work in hematopoietic receptor agonist proteins has the potential to impact medical science significantly. His patents and collaborations reflect his commitment to innovation and advancement in biochemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…